James Wilbur is Chief Commercial Officer of 10x Genomics, Inc.. Currently has a direct ownership of 83,342 shares of TXG, which is worth approximately $1.87 Million. The most recent transaction as insider was on Nov 22, 2023, when has been sold 3,464 shares (Class A Common Stock) at a price of $43.34 per share, resulting in proceeds of $150,129. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 83.3K
0% 3M change
24.88% 12M change
Total Value Held $1.87 Million

James Wilbur Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 22 2023
SELL
Open market or private sale
$150,129 $43.34 p/Share
3,464 Reduced 3.99%
83,342 Class A Common Stock
Nov 20 2023
SELL
Open market or private sale
$619,480 $42.09 p/Share
14,718 Reduced 14.5%
86,806 Class A Common Stock
Aug 22 2023
SELL
Open market or private sale
$444,020 $45.78 p/Share
9,699 Reduced 8.74%
101,253 Class A Common Stock
May 23 2023
SELL
Open market or private sale
$17,402 $55.07 p/Share
316 Reduced 0.28%
110,952 Class A Common Stock
Mar 21 2023
BUY
Grant, award, or other acquisition
-
14,555 Added 11.65%
110,394 Class A Common Stock
Sep 14 2022
BUY
Grant, award, or other acquisition
-
95,839 Added 50.0%
95,839 Class A Common Stock
JW

James Wilbur

Chief Commercial Officer
Pleasanton, CA

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG